Psoriasis
Psoriasis
Psoriasis is a chronic, immune-mediated inflammatory skin disease. In a healthy immune system, skin cells grow and shed over a period of nearly a month. In patients with psoriasis, an overactive immune system drastically accelerates this process to just a few days. The body cannot shed the cells fast enough, resulting in thick, scaly, and painful plaques building up on the skin's surface, driven by severe underlying Inflammation.
Epidemiology and Systemic Impact
According to the National Health Service (NHS), psoriasis affects around 2% of people in the UK. It is critical to understand that psoriasis is not merely a cosmetic skin condition; it is a systemic disease. Up to 30% of patients with psoriasis will eventually develop Psoriatic Arthritis, a destructive joint condition. Psoriasis is also heavily linked to metabolic syndrome, cardiovascular disease, and Obesity.
Clinical Classification of Psoriasis
Psoriasis can present in several distinct forms, which dictate the necessary pharmacological intervention:
Plaque Psoriasis
Accounting for about 80% to 90% of all cases, this phenotype is characterized by raised, inflamed, red skin covered with silvery-white scales. These plaques commonly appear on the elbows, knees, scalp, and lower back, and can be intensely itchy and painful.
Guttate Psoriasis
Often triggered by a bacterial infection like strep throat, guttate psoriasis appears as small, drop-shaped, scaling lesions on the trunk and limbs. It frequently affects children and young adults.
Inverse and Pustular Psoriasis
Inverse psoriasis affects the skin folds (groin, armpits, under the breasts) causing smooth, red lesions. Pustular psoriasis is a rare but severe form characterized by white, pus-filled blisters surrounded by inflamed skin, requiring immediate medical therapy.
Evidence-Based Pharmacological Treatments
The clinical management of psoriasis is highly customized, typically following a stepwise approach from topical creams for mild cases to powerful systemic and targeted oral therapies for moderate-to-severe disease.
Comparative Analysis of Systemic Oral Therapies
Below is a clinical overview of the prescription systemic medications available through our regulated pharmacy to manage severe psoriasis and psoriatic arthritis:
Medication (Brand) | Drug Class | Clinical Role in Psoriasis | Key Clinical Note |
|---|---|---|---|
Otezla (Apremilast) | PDE4 Inhibitor (Targeted) | Regulates inflammation within the cell to reduce redness, scaling, and joint pain. | A highly effective oral alternative to injectable biologics for moderate to severe plaque psoriasis. |
Trexall (Methotrexate) | DMARD | Suppresses the overactive immune system and drastically slows skin cell turnover. | The gold standard oral therapy for severe, disabling psoriasis and psoriatic arthritis. Taken once weekly. |
Medrol (Methylprednisolone) | Systemic Corticosteroid | Provides rapid, aggressive reduction of systemic inflammation. | Reserved strictly for short-term use during severe, acute psoriatic arthritis flare-ups. |
Clinical Safety Considerations
Systemic therapies like Trexall alter your immune system's response. While this clears the skin, it also leaves the patient more vulnerable to routine infections. Patients on systemic immunosuppressants require regular blood tests to monitor liver function and blood counts. For a comprehensive list of dermatological options, explore our Psoriasis Medications Catalog.
Frequently Asked Questions About Psoriasis
Is psoriasis contagious?
No. Psoriasis is entirely an autoimmune disease driven by genetics and immune system dysfunction. You cannot catch psoriasis from touching someone's skin plaques, sharing a towel, or swimming in the same pool.
Can stress cause my psoriasis to flare up?
Yes. Psychological stress is one of the most common and powerful triggers for psoriasis flares. High stress levels elevate cortisol and trigger systemic inflammation. Managing Anxiety Disorders and stress is considered a vital component of clinical psoriasis treatment.
Is there a permanent cure for psoriasis?
Currently, there is no permanent cure. However, with modern targeted oral therapies like Otezla or systemic DMARDs, the vast majority of patients can achieve "clear or almost clear" skin and maintain long-term remission, dramatically improving their quality of life.
Is it safe to order systemic psoriasis medications online?
Yes, provided you use a regulated clinical service. At Profarma Express, our independent prescribers rigorously review your dermatological history and current blood work parameters to ensure that systemic or targeted therapies are safe for your immune profile, delivering genuine medications securely to your door.
Treatment of Psoriasis
Because psoriasis is driven by the immune system, the clinical approach aims to interrupt the inflammatory cycle and normalize skin cell turnover. Treatment protocols depend entirely on the severity of the body surface area (BSA) affected:
First-Line Topical Therapies: For mild disease, prescription topical corticosteroids, Vitamin D analogues, or topical retinoids are applied directly to the plaques to reduce localized scaling and redness.
Targeted Oral Therapies: For moderate-to-severe plaque psoriasis, oral PDE4 inhibitors like Otezla are highly effective at regulating intracellular inflammation without the broad immunosuppression of traditional drugs.
Systemic DMARDs: In severe, disabling cases or when Psoriatic Arthritis is present, classical oral systemic drugs like Trexall (Methotrexate) are prescribed to suppress the aberrant immune response globally.
Phototherapy: Controlled clinical exposure to narrow-band UVB light can effectively slow rapid cell growth in patients unresponsive to topical treatments.
Systemic medications must be closely monitored by a healthcare provider to balance efficacy against potential immunosuppressive side effects.
Causes and Risk Factors of Psoriasis
Psoriasis is fundamentally an autoimmune disease. It occurs when T-cells (a type of white blood cell) mistakenly attack healthy skin cells, triggering a cascade of inflammatory responses and rapid cell overproduction. The primary clinical risk factors and triggers include:
Genetics and Heredity: Having a direct family member with psoriasis significantly increases your risk. Specific genetic markers (like HLA-Cw6) are strongly associated with the disease's onset.
Immune System Dysfunction: The core mechanism involves T-cells inappropriately triggering vasodilation and the hyperproliferation of keratinocytes (skin cells).
Psychological Stress: Severe emotional trauma or chronic Anxiety Disorders are definitively linked to the onset of the disease and acute flare-ups.
The Koebner Phenomenon: Psoriasis plaques frequently develop at the site of physical skin trauma, such as a severe sunburn, a scratch, surgical scars, or even a tattoo.
Metabolic Factors: Clinical data shows a profound correlation between psoriasis and Obesity. Excess adipose tissue produces pro-inflammatory cytokines that exacerbate the severity of psoriatic plaques.